Home/Filings/4/0001235802-18-000155
4//SEC Filing

Mainelli Michael 4

Accession 0001235802-18-000155

CIK 0001453593other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 4:08 PM ET

Size

10.0 KB

Accession

0001235802-18-000155

Insider Transaction Report

Form 4
Period: 2018-10-15
Transactions
  • Award

    Stock Option (right to buy)

    2018-10-15+240,000240,000 total
    Exercise: $3.22Exp: 2028-10-15Common Stock (240,000 underlying)
Holdings
  • Common Stock, $0.000001 par value

    20,833
Footnotes (2)
  • [F1]These shares are subject to vesting pursuant to a restricted stock award granted under the Amended and Restated Xtant Medical Equity Incentive Plan.
  • [F2]This option vests with respect to 10,000 of the shares subject to the option on the 15th day of each of the twenty-four (24) months commencing on November 15, 2018, subject to such Reporting Person's continued employment as Chief Executive Officer of Xtant Medical Holdings, Inc.

Issuer

Xtant Medical Holdings, Inc.

CIK 0001453593

Entity typeother

Related Parties

1
  • filerCIK 0001315983

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 4:08 PM ET
Size
10.0 KB